fenofibrate has been researched along with Carotid Artery Narrowing in 2 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Excerpt | Relevance | Reference |
---|---|---|
"Rosiglitazone treatment had no effect on protein levels but reduced activity by 73% of the control (P<0." | 1.35 | Modulation of endothelial cell thrombomodulin by PPAR ligands--variation according to environment. ( Clancy, P; Golledge, J; Mangan, S, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Golledge, J | 2 |
Mangan, S | 2 |
Clancy, P | 2 |
2 other studies available for fenofibrate and Carotid Artery Narrowing
Article | Year |
---|---|
Effects of peroxisome proliferator-activated receptor ligands in modulating tissue factor and tissue factor pathway inhibitor in acutely symptomatic carotid atheromas.
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Female; Fenofibrate; Humans; Ischemic Attack, Transient; | 2007 |
Modulation of endothelial cell thrombomodulin by PPAR ligands--variation according to environment.
Topics: Aorta; Atherosclerosis; Blotting, Western; Carotid Stenosis; Cells, Cultured; Dose-Response Relation | 2008 |